Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular basis for advances in cervical screening.

John Doorbar1, Heather Cubie

  • 1National Institute for Medical Research, The Ridgeway, Mill Hill, London, UK. jdoorbar@nimr.mrc.ac.uk

Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology
|November 8, 2005
PubMed
Summary

Human papillomaviruses (HPV) cause cervical cancer, a major global health issue. Advances in HPV DNA and RNA testing, alongside cytology, offer improved cervical cancer screening and early detection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATA3 Inhibits the Expression of Viral E6/E7 Genes, and Its Expression Is Compromised During HPV-Mediated Cervical Carcinogenesis.

Journal of medical virology·2026
Same author

Inhibition of high risk HPV31 E8^E2 repressor activity enables differentiation-independent genome amplification and E4 expression.

PLoS pathogens·2026
Same author

Regulation and Deregulation of Viral Gene Expression During High-Risk HPV Infection.

Viruses·2025
Same author

Role of Reserve Cells in Metaplasia and the Development of Human Papillomavirus-Associated High-Grade Squamous Intraepithelial Lesions at the Cervical Transformation Zone.

Laboratory investigation; a journal of technical methods and pathology·2025
Same author

How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection.

Tumour virus research·2025
Same author

Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma.

The EMBO journal·2024

Area of Science:

  • Gynecology
  • Oncology
  • Virology

Background:

  • Human papillomaviruses (HPVs) are a primary cause of cervical lesions, with potential progression to high-grade neoplasia and cancer.
  • Cervical cancer incidence remains high, particularly in developing nations, where it is a leading cause of cancer-related mortality.
  • Current cervical screening relies on cytology (Pap test), which has limitations including relatively high false-negative rates.

Purpose of the Study:

  • To explore advancements in cervical cancer screening beyond conventional cytology.
  • To evaluate the potential of molecular markers for improved detection and prognosis of cervical neoplasia.
  • To discuss the integration of HPV testing and other molecular approaches into cervical cancer screening strategies.

Main Methods:

Related Experiment Videos

  • Review of current cervical screening methods, including cytology and emerging molecular techniques.
  • Analysis of the role of human papillomavirus (HPV) infection in cervical carcinogenesis.
  • Exploration of novel biomarkers (DNA, RNA, protein) for detecting active HPV infections and cellular abnormalities.

    • Main Results:

    • Molecular markers, particularly those indicating active HPV infection or cell cycle involvement, show promise for enhancing detection rates compared to cytology alone.
    • HPV DNA testing, combined with enhanced cytology, is a rational approach based on the understanding of HPV as a precursor to cervical cancer.
    • RNA-based approaches can differentiate between latent and active HPV infections, potentially improving diagnostic precision.

    Conclusions:

    • Integrating molecular markers, such as HPV DNA and RNA detection, with cytology can significantly improve the accuracy and prognostic value of cervical cancer screening.
    • While HPV vaccination is crucial for prevention, ongoing screening remains essential due to the persistence of multiple high-risk HPV types and the lack of therapeutic vaccines.
    • Future screening strategies may evolve with vaccination impact and the development of more precise prognostic markers, but molecular testing will likely remain a cornerstone for cervical cancer control.